These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8568233)

  • 21. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells.
    Ohnuma K; Yamochi T; Uchiyama M; Nishibashi K; Iwata S; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Mol Cell Biol; 2005 Sep; 25(17):7743-57. PubMed ID: 16107720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
    Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
    Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
    Bopp A; De Bona KS; Bellé LP; Moresco RN; Moretto MB
    Fundam Clin Pharmacol; 2009 Aug; 23(4):501-7. PubMed ID: 19709327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and functional expression of the T cell activation antigen CD26.
    Tanaka T; Camerini D; Seed B; Torimoto Y; Dang NH; Kameoka J; Dahlberg HN; Schlossman SF; Morimoto C
    J Immunol; 1992 Jul; 149(2):481-6. PubMed ID: 1352530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation.
    Kähne T; Kröning H; Thiel U; Ulmer AJ; Flad HD; Ansorge S
    Cell Immunol; 1996 May; 170(1):63-70. PubMed ID: 8660800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells.
    Gonzalez-Gronow M; Hershfield MS; Arredondo-Vega FX; Pizzo SV
    J Biol Chem; 2004 May; 279(20):20993-8. PubMed ID: 15016824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
    Kameoka J; Tanaka T; Nojima Y; Schlossman SF; Morimoto C
    Science; 1993 Jul; 261(5120):466-9. PubMed ID: 8101391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
    Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS
    J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure and function of CD26 in the T-cell immune response.
    Morimoto C; Schlossman SF
    Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
    Dang NH; Hagemeister FB; Duvic M; Romaguera JE; Younes A; Jones D; Samuels B; Fayad LE; Pro B; Samaniego F; Sarris A; Goy A; McLaughlin P; Tong AT; Walker PL; Tiongson LP; Smith TL; Huh YO; Morimoto C; Rodriguez MA
    Oncol Rep; 2003; 10(5):1513-8. PubMed ID: 12883733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
    Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
    Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.
    Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
    Adv Exp Med Biol; 1997; 421():185-92. PubMed ID: 9330696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation: changes in expression pattern of adenosine kinase, adenosine deaminase, and 5'-nucleotidase.
    Spychala J; Mitchell BS; Barankiewicz J
    J Immunol; 1997 May; 158(10):4947-52. PubMed ID: 9144513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early phosphorylation events induced by DPIV/CD26-specific inhibitors.
    Kähne T; Neubert K; Faust J; Ansorge S
    Cell Immunol; 1998 Oct; 189(1):60-6. PubMed ID: 9758695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
    Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M
    J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity.
    Reinhold D; Kähne T; Steinbrecher A; Wrenger S; Neubert K; Ansorge S; Brocke S
    Biol Chem; 2002; 383(7-8):1133-8. PubMed ID: 12437097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occupancy of dipeptidyl peptidase IV activates an associated tyrosine kinase and triggers an apoptotic signal in human hepatocarcinoma cells.
    Gaetaniello L; Fiore M; de Filippo S; Pozzi N; Tamasi S; Pignata C
    Hepatology; 1998 Apr; 27(4):934-42. PubMed ID: 9537431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.